dihexa kidney toxicity Growth factors and their peptide mimetics for treatment of traumatic brain injury Factors contributing to opiate toxicity

Cancer / proliferation concern: Potentiating c-Met (a proto-oncogene product) raises a legitimate theoretical risk of promoting pre-existing or nascent malignancy

(PubMed) Agnoli C, Grioni S, Krogh V, et al

Weve won big against the government before we secured a $1.25 billion settlement on behalf of 15,700+ farmers who were discriminated against by the USDA

published the first major preclinical and early-phase characterization of this specific combination in The Lancet in 2021, reporting on cagrilintide co-administered with semaglutide in a Phase 1b dose-finding study (PubMed 34004180)

[DOI] [PubMed] [Google Scholar] 4